The article outlines five core barriers to patient recruitment in rare disease clinical trials, including low awareness and complex protocols. It emphasizes the need for tailored strategies to enhance participation and retention, crucial for advancing research in the face of over 10,000 known rare diseases.
Explore strategies to overcome barriers in rare disease patient recruitment, enhancing clinical trial participation and retention. Every missed patient in a rare disease clinical trial represents more than a recruitment challenge, it represents a missed opportunity to advance research for communities with limited treatment options. With more than 10,000 known rare diseases and only a small percentage with approved treatments, the need for continued research is clear. Key Takeaway: The article discusses the challenges of recruiting patients for rare disease clinical trials, identifying five core barriers: low awareness, complex protocols, competitive trial landscapes, patient hesitancy, and logistical limitations. It suggests tailored strategies to address these issues, emphasizing the importance of awareness, education, and support for patients throughout the recruitment process. Effective recruitment strategies can enhance patient participation and retention in clinical trials. Highlights the importance of rare disease research. Awareness remains one of the largest barriers in rare disease research. Patients, caregivers, and even healthcare providers may not recognize symptoms, connect those symptoms to a specific condition, or know that a clinical trial is available.
Original title: “Enhancing Rare Disease Trial Participation - MEDP”